Opyl Limited Appoints Megan Robertson as Non-Executive Director to its Board
May 04, 2021 at 09:27 pm EDT
Opyl Limited announced the appointment of Dr. Megan Robertson to the Opyl Board as a non-executive director, effective May 5, 2021 bringing extensive clinical trial expertise and experiences to the company. Megan is the current Group Chief Research Officer at St Vincent's Health Australia and Director of Research at St Vincent's Hospital, Melbourne. She also works as a Senior Intensive Care Consultant at Epworth HealthCare (Richmond and Freemasons).